Agile Therapeutics Inc (AGRX)
0.361
0.00 (0.00%)
USD |
OTCM |
May 31, 16:00
Agile Therapeutics Enterprise Value: -0.1399M for May 31, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 31, 2024 | -0.1399M |
| May 30, 2024 | -0.1193M |
| May 29, 2024 | -0.1193M |
| May 28, 2024 | 0.0178M |
| May 24, 2024 | -0.0446M |
| May 23, 2024 | -0.0446M |
| May 22, 2024 | 0.0178M |
| May 21, 2024 | 0.0795M |
| May 20, 2024 | -0.0508M |
| May 17, 2024 | -0.0254M |
| May 16, 2024 | 0.1243M |
| May 15, 2024 | -0.0128M |
| May 14, 2024 | -0.0251M |
| May 13, 2024 | -0.0096M |
| May 10, 2024 | -0.0405M |
| May 09, 2024 | -0.0439M |
| May 08, 2024 | 0.2283M |
| May 07, 2024 | 0.2283M |
| May 06, 2024 | 0.2283M |
| May 03, 2024 | 0.0178M |
| May 02, 2024 | 0.1604M |
| May 01, 2024 | 0.3983M |
| April 30, 2024 | 0.436M |
| April 29, 2024 | 0.3311M |
| April 26, 2024 | 0.1275M |
| Date | Value |
|---|---|
| April 25, 2024 | 0.1275M |
| April 24, 2024 | 0.1295M |
| April 23, 2024 | -0.0782M |
| April 22, 2024 | 0.0863M |
| April 19, 2024 | -0.0096M |
| April 18, 2024 | -0.0782M |
| April 17, 2024 | -0.0936M |
| April 16, 2024 | 0.0285M |
| April 15, 2024 | -0.0755M |
| April 12, 2024 | -0.119M |
| April 11, 2024 | 0.2657M |
| April 10, 2024 | -0.181M |
| April 09, 2024 | -0.0864M |
| April 08, 2024 | 0.0863M |
| April 05, 2024 | -0.6267M |
| April 04, 2024 | -0.6438M |
| April 03, 2024 | -0.696M |
| April 02, 2024 | -0.746M |
| April 01, 2024 | -0.7638M |
| March 31, 2024 | -0.2839M |
| March 28, 2024 | 1.480M |
| March 27, 2024 | 1.686M |
| March 26, 2024 | 0.1389M |
| March 25, 2024 | 0.9337M |
| March 22, 2024 | 0.7698M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-0.7638M
Minimum
Apr 01 2024
281.65M
Maximum
Feb 16 2021
72.72M
Average
46.97M
Median
Oct 04 2019
Enterprise Value Benchmarks
| Altimmune Inc | 350.45M |
| iBio Inc | 28.91M |
| Verastem Inc | 52.61M |
| Oragenics Inc | 8.699M |
| Actinium Pharmaceuticals Inc | 158.68M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 1.284M |
| Revenue (Quarterly) | 5.716M |
| Total Expenses (Quarterly) | 8.473M |
| EPS Diluted (Quarterly) | 0.28 |
| Gross Profit Margin (Quarterly) | 70.61% |
| Profit Margin (Quarterly) | 22.46% |
| Earnings Yield | -983.4% |
| Normalized Earnings Yield | -1816.00 |